|
|
Volumn 173, Issue 5, 2005, Pages 1583-1584
|
|
Urological oncology: Testis cancer and advances in oncological therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
ADENOVIRUS VECTOR;
CHORIONIC GONADOTROPIN BETA SUBUNIT;
THYMIDINE KINASE;
TUMOR MARKER;
BLADDER CANCER;
CANCER CELL CULTURE;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER INHIBITION;
CANCER LOCALIZATION;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER RELAPSE;
CANCER SURGERY;
CANCER SURVIVAL;
CANCER THERAPY;
CELL TYPE;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
DIARRHEA;
DISEASE SEVERITY;
DRUG ACTIVITY;
DRUG SCREENING;
EMBRYO CELL;
EVALUATION;
EXPERIMENT;
FOLLOW UP;
GENE EXPRESSION;
GENE TARGETING;
GERMANY;
HISTOPATHOLOGY;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
KAPLAN MEIER METHOD;
LYMPH NODE METASTASIS;
NAUSEA;
NONHUMAN;
NOTE;
NUDE MOUSE;
ONCOLOGY;
ORCHIECTOMY;
PARAAORTIC LYMPH NODE;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROMOTER REGION;
PROSPECTIVE STUDY;
PROSTATE CANCER;
PROTEIN BLOOD LEVEL;
RADIATION DOSE;
SALVAGE THERAPY;
SEMINOMA;
STANDARD;
SURVIVAL RATE;
SURVIVAL TIME;
TESTIS CANCER;
TESTIS CELL;
TISSUE SPECIFICITY;
TOXICITY;
TREATMENT OUTCOME;
VIRAL GENE DELIVERY SYSTEM;
VIRAL GENE THERAPY;
VIRUS RECOMBINANT;
|
|
EID: 17144382880
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1097/01.ju.0000157373.51147.98 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|